Latest: FDA Approves New Biosimilar for Oncology Treatment

Amalgam Rx Secures $20M to Accelerate AI-Powered Healthcare Solutions

0 Mins
What You Should Know: – Amalgam Rx, a company specializing in data-driven healthcare decision-making, has announced a $20M credit investment from Catalio Capital Management. – The $20M senior secured term loan provides Amalgam with an initial draw of $12M to support its market expansion and refinance existing corporate debt. The credit investment also gives Amalgam ... Read More
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago